New cancer drug trial targets Hard-to-Treat tumors
NCT ID NCT07488676
Summary
This study is testing a new drug called ASP546C for people with advanced stomach, pancreatic, and other cancers that have spread or cannot be removed by surgery. The main goals are to find a safe dose and see if the drug can shrink tumors. About 150 participants will receive the drug through an IV infusion every three weeks.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.